These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
621 related articles for article (PubMed ID: 19376121)
21. Clinical significance of tumor-infiltrating lymphocytes in lung neoplasms. Ruffini E; Asioli S; Filosso PL; Lyberis P; Bruna MC; Macrì L; Daniele L; Oliaro A Ann Thorac Surg; 2009 Feb; 87(2):365-71; discussion 371-2. PubMed ID: 19161739 [TBL] [Abstract][Full Text] [Related]
22. Factors influencing survival after bypass procedures in patients with advanced pancreatic adenocarcinomas. Müller MW; Friess H; Köninger J; Martin D; Wente MN; Hinz U; Ceyhan GO; Blaha P; Kleeff J; Büchler MW Am J Surg; 2008 Feb; 195(2):221-8. PubMed ID: 18154768 [TBL] [Abstract][Full Text] [Related]
23. Long term survival after pancreatic resection for pancreatic adenocarcinoma. Ahmad NA; Lewis JD; Ginsberg GG; Haller DG; Morris JB; Williams NN; Rosato EF; Kochman ML Am J Gastroenterol; 2001 Sep; 96(9):2609-15. PubMed ID: 11569683 [TBL] [Abstract][Full Text] [Related]
24. The natural history of resected pancreatic cancer without adjuvant chemotherapy. Hernandez JM; Morton CA; Al-Saadi S; Villadolid D; Cooper J; Bowers C; Rosemurgy AS Am Surg; 2010 May; 76(5):480-5. PubMed ID: 20506876 [TBL] [Abstract][Full Text] [Related]
26. Prognostic factors in resected pancreatic adenocarcinoma: analysis of actual 5-year survivors. Cleary SP; Gryfe R; Guindi M; Greig P; Smith L; Mackenzie R; Strasberg S; Hanna S; Taylor B; Langer B; Gallinger S J Am Coll Surg; 2004 May; 198(5):722-31. PubMed ID: 15110805 [TBL] [Abstract][Full Text] [Related]
27. S100A2, a potential marker for early recurrence in early-stage oral cancer. Tsai ST; Jin YT; Tsai WC; Wang ST; Lin YC; Chang MT; Wu LW Oral Oncol; 2005 Apr; 41(4):349-57. PubMed ID: 15792606 [TBL] [Abstract][Full Text] [Related]
28. Over-expression of S100A2 in pancreatic cancer correlates with progression and poor prognosis. Ohuchida K; Mizumoto K; Miyasaka Y; Yu J; Cui L; Yamaguchi H; Toma H; Takahata S; Sato N; Nagai E; Yamaguchi K; Tsuneyoshi M; Tanaka M J Pathol; 2007 Nov; 213(3):275-82. PubMed ID: 17940995 [TBL] [Abstract][Full Text] [Related]
29. Combined c-Myc and caveolin-1 expression in human prostate carcinoma predicts prostate carcinoma progression. Yang G; Timme TL; Frolov A; Wheeler TM; Thompson TC Cancer; 2005 Mar; 103(6):1186-94. PubMed ID: 15712208 [TBL] [Abstract][Full Text] [Related]
30. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma. Pfannschmidt J; Bade S; Hoheisel J; Muley T; Dienemann H; Herpel E Thorac Cardiovasc Surg; 2009 Oct; 57(7):403-8. PubMed ID: 19795327 [TBL] [Abstract][Full Text] [Related]
31. The impact of spontaneous tumour perforation on outcome following colon cancer surgery. Abdelrazeq AS; Scott N; Thorn C; Verbeke CS; Ambrose NS; Botterill ID; Jayne DG Colorectal Dis; 2008 Oct; 10(8):775-80. PubMed ID: 18266887 [TBL] [Abstract][Full Text] [Related]
32. Is peritoneal cytology a predictor of unresectability in pancreatic carcinoma? Schmidt J; Fraunhofer S; Fleisch M; Zirngibl H Hepatogastroenterology; 2004; 51(60):1827-31. PubMed ID: 15532836 [TBL] [Abstract][Full Text] [Related]
33. Predictors of long-term survival after resection of esophageal carcinoma with nonregional nodal metastases. Lee PC; Port JL; Paul S; Stiles BM; Altorki NK Ann Thorac Surg; 2009 Jul; 88(1):186-92; discussion 192-3. PubMed ID: 19559222 [TBL] [Abstract][Full Text] [Related]
34. Role of lymph node density in predicting survival of patients with lymph node metastases after radical cystectomy: a multi-institutional study. Osawa T; Abe T; Shinohara N; Harabayashi T; Sazawa A; Kubota K; Matsuno Y; Shibata T; Shinno Y; Kamota S; Minami K; Sakashita S; Kumagai A; Mori T; Nonomura K Int J Urol; 2009 Mar; 16(3):274-8; discussion 278. PubMed ID: 19087211 [TBL] [Abstract][Full Text] [Related]
35. Multimodality therapy for pancreatic cancer in the U.S. : utilization, outcomes, and the effect of hospital volume. Bilimoria KY; Bentrem DJ; Ko CY; Tomlinson JS; Stewart AK; Winchester DP; Talamonti MS Cancer; 2007 Sep; 110(6):1227-34. PubMed ID: 17654662 [TBL] [Abstract][Full Text] [Related]
36. The ratio of metastatic/resected lymph nodes is an independent prognostic factor in patients with node-positive pancreatic head cancer. Sierzega M; Popiela T; Kulig J; Nowak K Pancreas; 2006 Oct; 33(3):240-5. PubMed ID: 17003644 [TBL] [Abstract][Full Text] [Related]
37. Copy number of chromosome 17 but not HER2 amplification predicts clinical outcome of patients with pancreatic ductal adenocarcinoma. Stoecklein NH; Luebke AM; Erbersdobler A; Knoefel WT; Schraut W; Verde PE; Stern F; Scheunemann P; Peiper M; Eisenberger CF; Izbicki JR; Klein CA; Hosch SB J Clin Oncol; 2004 Dec; 22(23):4737-45. PubMed ID: 15570074 [TBL] [Abstract][Full Text] [Related]